AQST
Aquestive Therapeutics, Inc.
$4.00
-3.15%
2026-10-23
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy; KYNMOBI, a sublingual film formulation of apomorphine; and AZSTARYS, an fda-approved, once-daily product for the treatment of ADHD in patients age 6 years or older. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.
Key Fundamentals
Forward P/E
-8.21
EPS (TTM)
$-0.66
Revenue Growth (YoY)
38.1%
Profit Margin
-144.6%
Price/Book
-10.38
Beta
1.47
Market Cap
$587.4M
Avg Volume (10D)
2.6M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$5.49
60D Low
$3.61
Avg Volume
2.8M
Latest Close
$4.00
Get breakout alerts for AQST
Sign up for Breakout Scanner to receive daily notifications when AQST triggers breakout signals. Build custom AI screeners and backtest strategies.
Create your account7-day free trial, no card needed. Then $20/month.
Aquestive Therapeutics, Inc. (AQST) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors AQST daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. AQST operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.